Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - apomorphine hydrochloride - oral tablet - apomorphine hydrochloride alkaloid active 6.5 mg/tb - central nervous system - dog | bitch | castrate | puppy - emetic | induce vomiting

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium citrate dihydrate; sodium chloride - ondansetron injection is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - apomorphine hydrochloride hemihydrate 2mg - sublingual tablet - 2 mg - active: apomorphine hydrochloride hemihydrate 2mg excipient: acesulfame potassium ascorbic acid citric acid colloidal silicon dioxide disodium edetate dihydrate entrapped cool mint orange hypromellose iron oxide red magnesium stearate mannitol powdered cellulose

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - apomorphine hydrochloride hemihydrate 3mg - sublingual tablet - 3 mg - active: apomorphine hydrochloride hemihydrate 3mg excipient: acesulfame potassium ascorbic acid citric acid colloidal silicon dioxide disodium edetate dihydrate entrapped cool mint orange hypromellose iron oxide red magnesium stearate mannitol powdered cellulose

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - apomorphine hydrochloride hemihydrate 30mg;   - solution for injection - 30 mg/3ml - active: apomorphine hydrochloride hemihydrate 30mg   excipient: hydrochloric acid sodium hydroxide sodium metabisulfite water for injection - apomine intermittent injection is indicated to reduce the number and severity of 'off' phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomine intermittent should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during 'on' phases.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 2.5 mg/ml (equivalent: ondansetron, qty 2 mg/ml) - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; sodium citrate dihydrate; water for injections - ondansetron injection is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 2.5 mg/ml (equivalent: ondansetron, qty 2 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid monohydrate; sodium citrate dihydrate - ondansetron injection is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.98 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; sodium citrate dihydrate; citric acid monohydrate - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.